Navigation Links
PDL BioPharma Announces Fourth Quarter and Full Year 2012 Financial Results
Date:3/1/2013

INCLINE VILLAGE, Nev., March 1, 2013 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the fourth quarter and full year ended December 31, 2012.

(Logo:  http://photos.prnewswire.com/prnh/20110822/SF55808LOGO)

Total revenues in 2012 were $374.5 million, compared to $362.0 million in 2011, with royalty revenues increasing seven percent over full year 2011. For the fourth quarter of 2012, total revenues were $86.0 million, compared to $72.8 million in the fourth quarter of 2011.

Royalty revenues for the fourth quarter of 2012 are based on third quarter product sales by PDL's licensees. The fourth quarter 2012 revenue growth was primarily driven by increased royalties from third quarter 2012 sales of Herceptin® and Avastin®, which are marketed by Genentech and Roche.  Royalty revenue for the fourth quarter and 2012 are net of payments made under our February 2011 settlement agreement with Novartis Pharma AG.

Operating expenses in 2012 were $25.5 million, compared with $18.3 million in 2011. For the fourth quarter of 2012, general and administrative expenses were $7.7 million compared with $4.8 million for the same period of 2011.

Net income in 2012 was $211.7 million, or $1.45 per diluted share as compared with net income of $199.4 million in 2011 or $1.15 per diluted share. Net income for the fourth quarter of 2012 was $49.4 million or $0.34 per diluted share as compared with net income of $38.9 million or $0.24 per diluted share for the same period of 2011.

Net cash provided by operating activities in 2012 was $210.2 million, compared with $169.8 million in 2011. At December 31, 2012, PDL had cash, cash equivalents and investments of $148.7 million, compared with $227.9 million at
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Biopharma M&A Trends Hold Steady, But Deals Declined in 2011
2. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
3. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
4. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
5. Genesis Biopharma Announces Termination of Previously Announced Proposed Public Offering
6. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
7. S1 Biopharma Expands Focus to Include Male Sexual Health
8. New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
9. Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
10. Cell Therapeutics Aequus BioPharma Validates its Proprietary GlycoPolymer Technology for the Extension of the Half-life of Therapeutic Protein Drugs
11. Galena Biopharma, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... , July 30, 2014 Stryker brand ambassadors ... week at the 3M Championship Champions Tour event near ... in Blaine . Stryker is the official joint ... Starting Friday, August 1 st through Sunday, August ... Mobility Zone; an on-site joint health destination located in the Pioneer ...
(Date:7/30/2014)... and KISSING, Germany , July 30, ... a single use and computer-assisted ("robotic") colonoscopy system, today ... a worldwide recognized medical device executive, as a new ... Shamir is a highly respected global visionary in the ... served as President and Chief Executive Officer at Given ...
(Date:7/30/2014)... 2014 Cynosure, Inc. (NASDAQ: ... for non-invasive and minimally invasive applications, today announced that the ... Officer and Chief Financial Officer Timothy W. Baker ... 53, will continue to serve as CFO and will take ... remains Chairman and Chief Executive Officer. "Tim ...
Breaking Medicine Technology:Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 2Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 3Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 4Stryker Brand Ambassadors Fred Funk And Hal Sutton Set To Play At 3M Championship 5invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 3Cynosure Appoints Chief Operating Officer and Chief Financial Officer Timothy W. Baker as President 2
... Innophos Holdings, Inc. (Nasdaq: IPHS ) today ... of $0.25 per share of common stock, payable on April ...  The new rate represents an increase of 47% over the ... paid cash dividends at the previous rate continuously since it ...
... Group, Inc., a leading provider of drug development services ... industries, announces its participation at the 19th Annual Partnerships ... 30 to April 1. PharmaNet and industry experts will ... March 31 Impact of Reform ...
Cached Medicine Technology:Innophos Holdings, Inc. Declares Dividend of $0.25 Per Share; Increases Rate By 47% 2PharmaNet Shares Expertise in Drug Development Outsourcing at the 2011 Partnerships in Clinical Trials Conference 2
(Date:7/30/2014)... NJ (PRWEB) July 30, 2014 ... ® company, today announced that DollarPhone, the largest ... America, selected the Dialogic® ControlSwitch™ softswitch ... and local number portability (LNP) to both its ... architecture, Dialogic’s ControlSwitch is able to power DollarPhone’s ...
(Date:7/30/2014)... Kathleen Doheny HealthDay Reporter ... a young age might set the stage for harmful health ... of college-age women conducted from 1982 to 2012 also found ... abuse. "The younger a woman was when she started ... use extreme weight control behaviors -- like vomiting or laxative ...
(Date:7/30/2014)... MN (PRWEB) July 30, 2014 Loffler ... the upper Midwest, is pleased to announce new production ... busy work places print faster, smarter and better. , ... the Konica Minolta bizhub PRESS C1100 color press raises ... production floor and saves time and labor costs with ...
(Date:7/30/2014)... BuyCBDOnline.co , the web's leading ... to announce that it is has made available through ... products available for immediate shipping. , "We have to ... stages," site founder Jason Liss says. "For being such ... of unique products that are available or will be ...
(Date:7/30/2014)... 2014 Running season is in full ... aims to help runners keep running. Dr Shoshany will ... continue training. He has recently began implementing an expanded, ... Cold Laser Therapy, Graston technique and kinesiology taping to ... Dr Shoshany often combines chiropractic , and physical ...
Breaking Medicine News(10 mins):Health News:DollarPhone Expands Prepaid and Wholesale Offerings With Enhanced Dialogic ControlSwitch 2Health News:DollarPhone Expands Prepaid and Wholesale Offerings With Enhanced Dialogic ControlSwitch 3Health News:Dieting at Young Age Often Backfires, Study Says 2Health News:Dieting at Young Age Often Backfires, Study Says 3Health News:Loffler Companies Introduces New Konica Minolta bizhub PRESS C1085/C1100 and Canon imagePRESS C800/C700 Devices 2Health News:Loffler Companies Introduces New Konica Minolta bizhub PRESS C1085/C1100 and Canon imagePRESS C800/C700 Devices 3Health News:Delicious, Unique CBD-Rich Hemp Oil Product Debuts from BuyCBDOnline.co 2Health News:Delicious, Unique CBD-Rich Hemp Oil Product Debuts from BuyCBDOnline.co 3Health News:Chiropractor Helping Runners Keep Going with New Integrated Treatment Protocols 2Health News:Chiropractor Helping Runners Keep Going with New Integrated Treatment Protocols 3
... of the chest, abdomen, and pelvis, a technique called CT ... and/or lumbar spine to detect spinal fractures. This technique can ... study to be presented at the ARRS 2010 Annual Meeting ... by a CT technician after a CT scan is complete. ...
... ... ... -- A novel electronic device developed by an Allegheny General Hospital (AGH) physician ... way to monitor the hand hygiene compliance of health care workers, according to a study ...
... ... set…GO! Summer kicks off each year with the City of Laguna ... year, the event is expected to bring out more than 6,000 runners, ... Day – Monday May 31. Registration is available online at www.lagunahillshalfmarathon.com ...
... ... place as one of the world,s leading medical hubs as it performs an intricate ... debilitating condition. , ... Singapore (PRWEB), May 6, 2010 -- Singapore,s oldest and largest tertiary acute hospital and ...
... Whole body magnetic resonance imaging (MRI) should be the imaging ... (when the cancer has spread beyond the breast) as it ... patient is still asymptomatic (shows no symptoms), according to a ... in San Diego, CA. Whole body MRI is a ...
... MAY 6, 2010 Results from the SPIRIT IV ... Cardiovascular Therapeutics (TCT) 2009 scientific symposium, were published today ... Data from the trial, a large-scale multi-center study ... everolimus-eluting stents demonstrated enhanced safety and efficacy in the ...
Cached Medicine News:Health News:CT technique eliminates the need for X-rays in trauma patients with possible spinal fractures 2Health News:Innovative Technology Developed at AGH Accurately Monitors Healthcare Professionals' Handwashing Practices, Study Shows , 2Health News:Innovative Technology Developed at AGH Accurately Monitors Healthcare Professionals' Handwashing Practices, Study Shows , 3Health News:City of Laguna Hills Announces Memorial Day Half Marathon and 5K 2Health News:Singapore Performs Asia's First Combined Heart and Liver Transplant 2Health News:Singapore Performs Asia's First Combined Heart and Liver Transplant 3Health News:Singapore Performs Asia's First Combined Heart and Liver Transplant 4Health News:Singapore Performs Asia's First Combined Heart and Liver Transplant 5Health News:Whole body MRI is highly accurate in the early detection of breast cancer metastases 2Health News:Study finds everolimus-eluting stent safer, more effective than paclitaxel-eluting stent 2
... complete imaging access, with nearly 100 percent ... imaging C-Arms can pan from head to ... patient. Anesthesiologists will appreciate this table for ... construction, and ease of operation. The key ...
...
LiquichekCardiac Markers Plus Control LT is a premium, comprehensive cardiac assessment control with many analytes and long stability....
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
Medicine Products: